Australia MDMA

Filament’s Psilocybin, Tested On Mild Cognitive Impairment By CAMH Clinical-stage natural psychedelic drug development company Filament Health Corp. (OTCQB: FLHLF) has inked a second supply deal with Canada-based Centre for Addiction and Mental Health (CAMH) concerning its botanical...

Mining industry billionaire Andrew Forrest recently recognized the potential of the burgeoning cannabis industry by taking a $5 million stake in a Perth-based health technology company Emyria (ASX: EMD), which focuses on new marijuana and psychedelic treatment. By investing $5...